The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2

Background & Objective: The prominent growth in the statistics of the patients with Diabetes Mellitus (DM) and the danger of its complication states a necessity to focus on finding new ways to control it. The present study then was performed to survey the effect of L-Arginin supplementation on...

Full description

Bibliographic Details
Main Authors: sara asadi, hasan mozaffari khosravi, MahnazMehdi Rahimi, Mohammad Mehdi Naghizadeh
Format: Article
Language:fas
Published: Fasa University of Medical Sciences 2014-06-01
Series:Journal of Fasa University of Medical Sciences
Subjects:
Online Access:http://journal.fums.ac.ir/browse.php?a_code=A-10-557-1&slc_lang=en&sid=1
id doaj-7c74bbec5dd9438880f7042514dd5982
record_format Article
spelling doaj-7c74bbec5dd9438880f7042514dd59822020-11-24T22:54:35ZfasFasa University of Medical SciencesJournal of Fasa University of Medical Sciences2228-51052228-73292014-06-014199110The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2sara asadi0hasan mozaffari khosravi1MahnazMehdi Rahimi2Mohammad Mehdi Naghizadeh3 Fasa University of Medical Sciences Shahid Sadoughi University of Medical Sciences-Yazd Fasa University of Medical Sciences Shiraz University of Medical Science Background & Objective: The prominent growth in the statistics of the patients with Diabetes Mellitus (DM) and the danger of its complication states a necessity to focus on finding new ways to control it. The present study then was performed to survey the effect of L-Arginin supplementation on the metabolism of sugar and lipid profiles in patients with diabetes type 2. Materials & Methods: In a randomized double-blind clinical trial, 75 patients with diabetes type 2 were divided into three groupsrandomly: 1. 3 gr L-Arginin per day, 2. 6 gr L-Arginin per day and 3. The placebo group. Height, weight, waist, High Density Lipoprotein (HDL), Triglycerides (TG), Low Density ipoprotein (LDL), and the total cholesterol were measured before and after three months of intervention. Results: no significant change was made in any of the lipid parameters in the intervention group. However, the two means of cholesterol and LDL decreased from169.12±34.83 mg/dl to 142.08±32.13mg/dl(P-Value<0.001) and from 96.80±35.46mg/dl to 86.64±32.65(P-Value=0.001), respectively though The changes in TG and HDL were not significant. Conclusion: Daily consumption of six gram L-Arginin during three months improves the lipid profiles in patients with Diabetes type2. Nevertheless, the dosage of three gram in a day of this supplement has no effect on the blood lipids status. http://journal.fums.ac.ir/browse.php?a_code=A-10-557-1&slc_lang=en&sid=1Garlic lead kidney rat.
collection DOAJ
language fas
format Article
sources DOAJ
author sara asadi
hasan mozaffari khosravi
MahnazMehdi Rahimi
Mohammad Mehdi Naghizadeh
spellingShingle sara asadi
hasan mozaffari khosravi
MahnazMehdi Rahimi
Mohammad Mehdi Naghizadeh
The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
Journal of Fasa University of Medical Sciences
Garlic
lead
kidney
rat.
author_facet sara asadi
hasan mozaffari khosravi
MahnazMehdi Rahimi
Mohammad Mehdi Naghizadeh
author_sort sara asadi
title The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
title_short The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
title_full The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
title_fullStr The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
title_full_unstemmed The Effect of L-Arginin Supplementation on lipid profiles in patients with diabetes type 2
title_sort effect of l-arginin supplementation on lipid profiles in patients with diabetes type 2
publisher Fasa University of Medical Sciences
series Journal of Fasa University of Medical Sciences
issn 2228-5105
2228-7329
publishDate 2014-06-01
description Background & Objective: The prominent growth in the statistics of the patients with Diabetes Mellitus (DM) and the danger of its complication states a necessity to focus on finding new ways to control it. The present study then was performed to survey the effect of L-Arginin supplementation on the metabolism of sugar and lipid profiles in patients with diabetes type 2. Materials & Methods: In a randomized double-blind clinical trial, 75 patients with diabetes type 2 were divided into three groupsrandomly: 1. 3 gr L-Arginin per day, 2. 6 gr L-Arginin per day and 3. The placebo group. Height, weight, waist, High Density Lipoprotein (HDL), Triglycerides (TG), Low Density ipoprotein (LDL), and the total cholesterol were measured before and after three months of intervention. Results: no significant change was made in any of the lipid parameters in the intervention group. However, the two means of cholesterol and LDL decreased from169.12±34.83 mg/dl to 142.08±32.13mg/dl(P-Value<0.001) and from 96.80±35.46mg/dl to 86.64±32.65(P-Value=0.001), respectively though The changes in TG and HDL were not significant. Conclusion: Daily consumption of six gram L-Arginin during three months improves the lipid profiles in patients with Diabetes type2. Nevertheless, the dosage of three gram in a day of this supplement has no effect on the blood lipids status.
topic Garlic
lead
kidney
rat.
url http://journal.fums.ac.ir/browse.php?a_code=A-10-557-1&slc_lang=en&sid=1
work_keys_str_mv AT saraasadi theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT hasanmozaffarikhosravi theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT mahnazmehdirahimi theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT mohammadmehdinaghizadeh theeffectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT saraasadi effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT hasanmozaffarikhosravi effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT mahnazmehdirahimi effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
AT mohammadmehdinaghizadeh effectoflargininsupplementationonlipidprofilesinpatientswithdiabetestype2
_version_ 1725658925897875456